Al-Dawaa Medical Services Company
4163.SR
| Exchange: | SR |
| Currency | Saudi riyal |
| ISIN: | SA15H14I11H6 |
| Primary Ticker: | 4163.SR |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Pharmaceutical Retailers |
| Gic Sector: | Consumer Staples |
| Gic Group: | Consumer Staples Distribution & Retail |
| Gic Industry: | Consumer Staples Distribution & Retail |
| Gic Sub Industry: | Drug Retail |
| Description: | Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products. It is also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marketing services on behalf of third parties, as well as acting as a pharmaceutical agent. The company sells its pharmaceutical products through a network of pharmacies, as well as online and wholesale channels. Further, it engages in the manufacture of single-use medical products, consumables, medical examination tables, surgical furniture, beds with mechanical motion additives, medical thermometers, respirators, and medical anesthesia solutions; granting marketing licenses for pharmaceutical products, consumer goods, and food products; and provision of health care management consulting, as well as delivery services via electronic platforms. The company was founded in 1993 and is based in Khobar, the Kingdom of Saudi Arabia. |
| Address: | Eastern Cement Towers, Khobar, Saudi Arabia |
| Website: | https://www.al-dawaa.com.sa |
| Full Time Employees: | 6359 |
| Updated On: | 2024-11-03 |
Highlights
| Market Capitalization: | 7514000384 |
| Market Capitalization Mln: | 7514.00 |
| EBITDA: | 655829760 |
| PE Ratio: | 21.19 |
| Wall Street Target Price: | 115.3 |
| Book Value: | 16.20 |
| Dividend Share: | 1.87 |
| Dividend Yield: | 0.01 |
| Earnings Share: | 4.17 |
| EPS Estimate Current Year: | 4.71 |
| EPS Estimate Next Year: | 5.34 |
| EPS Estimate Current Quarter: | 1.27 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.05 |
| Operating Margin TTM: | 0.08 |
| Return On Assets TTM: | 0.06 |
| Return On Equity TTM: | 0.26 |
| Revenue TTM: | 5999725568 |
| Revenue Per Share TTM: | 70.58 |
| Quarterly Revenue Growth YOY: | 0.10 |
| Gross Profit TTM: | 1977373023 |
| Diluted Eps TTM: | 4.17 |
| Quarterly Earnings Growth YOY: | 0.07 |
Valuation
| Trailing PE: | 21.19 |
| Price Sales TTM: | 1.25 |
| Price Book MRQ: | 5.45 |
| Enterprise Value: | 9594817057 |
| Enterprise Value Revenue: | 1.59 |
| Enterprise Value Ebitda: | 11.13 |
Shares
| Shares Outstanding: | 85000000 |
| Shares Float: | 25633450 |
| Percent Insiders: | 68.81 |
| Percent Institutions: | 2.56 |
Technicals
| Beta: | 0.01 |
| 52 Week High: | 120.70 |
| 52 Week Low: | 80.30 |
| 50 Day MA: | 92.61 |
| 200 Day MA: | 96.78 |
Splits & Dividends
| Forward Annual Dividend Rate: | 1.25 |
| Forward Annual Dividend Yield: | 0.01 |
| Payout Ratio: | 0.59 |
| Ex Dividend Date: | 2024-08-12 |
Earnings
| Report Date: | 2025-05-22 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Currency: | SAR |
| Report Date: | 2023-03-21 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Currency: | SAR |
| Eps Actual: | 1.05 |
| Report Date: | 2022-11-02 |
| Date: | 2022-09-30 |
| Before After Market: | Before Market |
| Currency: | SAR |
| Eps Actual: | 0.57 |
| Eps Difference: | 0.57 |
| Report Date: | 2022-08-23 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | SAR |
| Eps Actual: | 1.05 |
| Eps Difference: | 1.05 |
| Report Date: | 2022-05-19 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | SAR |
| Eps Actual: | 1.02 |
| Eps Difference: | 1.02 |
| Report Date: | 2022-03-30 |
| Date: | 2021-12-31 |
| Before After Market: | Before Market |
| Currency: | SAR |
| Eps Actual: | 0.62 |
| Eps Difference: | 0.62 |
| Date: | 2025-12-31 |
| Period: | +1y |
| Growth: | 0.13 |
| Earnings Estimate Avg: | 5.34 |
| Earnings Estimate Low: | 5.08 |
| Earnings Estimate High: | 5.84 |
| Earnings Estimate Year Ago Eps: | 4.71 |
| Earnings Estimate Number Of Analysts: | 3.00 |
| Earnings Estimate Growth: | 0.13 |
| Revenue Estimate Avg: | 6644670000.00 |
| Revenue Estimate Low: | 6580000000.00 |
| Revenue Estimate High: | 6729000000.00 |
| Revenue Estimate Number Of Analysts: | 3.00 |
| Revenue Estimate Growth: | 0.06 |
| Eps Trend Current: | 5.34 |
| Eps Trend7days Ago: | 5.34 |
| Eps Trend30days Ago: | 5.34 |
| Eps Trend60days Ago: | 5.37 |
| Eps Trend90days Ago: | 5.50 |
| Date: | 2024-12-31 |
| Growth: | 0.21 |
| Earnings Estimate Avg: | 4.71 |
| Earnings Estimate Low: | 4.60 |
| Earnings Estimate High: | 4.78 |
| Earnings Estimate Year Ago Eps: | 3.87 |
| Earnings Estimate Number Of Analysts: | 4.00 |
| Earnings Estimate Growth: | 0.21 |
| Revenue Estimate Avg: | 6216940000.00 |
| Revenue Estimate Low: | 6136000000.00 |
| Revenue Estimate High: | 6315760000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.08 |
| Eps Trend Current: | 4.71 |
| Eps Trend7days Ago: | 4.71 |
| Eps Trend30days Ago: | 4.71 |
| Eps Trend60days Ago: | 4.69 |
| Eps Trend90days Ago: | 4.67 |
| Date: | 2024-09-30 |
| Period: | +1q |
| Date: | 2024-06-30 |
| Earnings Estimate Avg: | 1.27 |
| Earnings Estimate Low: | 1.27 |
| Earnings Estimate High: | 1.27 |
| Earnings Estimate Number Of Analysts: | 1.00 |
| Revenue Estimate Avg: | 1521000000.00 |
| Revenue Estimate Low: | 1509000000.00 |
| Revenue Estimate High: | 1545000000.00 |
| Revenue Estimate Number Of Analysts: | 3.00 |
| Revenue Estimate Growth: | 0.05 |
| Eps Trend Current: | 1.27 |
| Eps Trend7days Ago: | 1.27 |
| Date: | 2022-12-31 |
| Eps Actual: | 3.6 |
| Date: | 2021-12-31 |
| Eps Actual: | 0.6 |